Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00163566 · ClinicalTrials.gov registry record · Phase 2
Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80
A Phase 2 study, sponsored by ASCEND Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 128
- Enrollment target
NCT00163566: Completed Phase 2 study, sponsored by ASCEND Therapeutics.
NCT00163566 is a Phase 2 study that has completed, run by ASCEND Therapeutics. The registered enrollment target is 128 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00163566, a Phase 2 study, has completed, sponsored by ASCEND Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 128 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether DHT-Gel, when applied daily to the skin, can relieve the symptoms of low testosterone in men aged 55-80. These symptoms include reduced muscle strength, increase fat mass, low libido, feeling blue or moody
Interventions
- DRUG Dihydrotestosterone (0.7%) in hydroalcoholic gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2004-10 |
| Est. Completion | 2006-09-25 |
| Phase | Phase 2 |
What the finished NCT00163566 record still lists
NCT00163566 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Dihydrotestosterone (0.7%) in hydroalcoholic gel is the first listed.
NCT00163566 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00163566 about?
NCT00163566 is a clinical study titled "Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80". The purpose of this study is to evaluate whether DHT-Gel, when applied daily to the skin, can relieve the symptoms of low testosterone in men aged 55-80. These symptoms include reduced muscle strength, increase fat mass, low libido, feeling blue or moody
What is the current status of trial NCT00163566?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 128 participants. The study started on 2004-10. Estimated completion is 2006-09-25.
What interventions are being tested in trial NCT00163566?
The interventions under investigation include: Dihydrotestosterone (0.7%) in hydroalcoholic gel (DRUG).
Who is sponsoring clinical trial NCT00163566?
This trial is sponsored by ASCEND Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00163566's enrollment target sits among peer trials
128 553rd of 2000 higher than 1,446 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia